Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology

NCT04296201 is registered in ClinicalTrials.gov with Lumenis Be Ltd. as lead sponsor.

NCT NCT04296201
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04296201 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Immediate Effect and Safety of DMA™ Novel Muscle Stimulation Technology
Lead sponsor
Lumenis Be Ltd.
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2020
Completion date
February 15, 2021
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

muscle contracture, skin laxity